What Mozobil contains
- The active substance is plerixafor. Each ml solution for injection contains 20 mg plerixafor. Each vial contains 24 mg plerixafor in 1.2 ml solution.
- The other ingredients are sodium chloride, hydrochloric acid (concentrated) and sodium hydroxide for pH adjustment and water for injections.
What Mozobil looks like and contents of the pack
Mozobil is supplied as a clear colourless or pale yellow solution for injection in a glass vial with a non-latex rubber stopper. Each vial contains 1.2 ml solution.
Each pack contains 1 vial.
Marketing Authorisation Holder
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, The Netherlands.
Manufacturer
Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
ItaliaMalta Genzyme Srl ItaliaItalja Tel 39 059 349 811 BelgiëBelgiqueBelgien LuxemburgLuxembourg Genzyme Belgium N.V. TelTél 32 2 714 17 11
Magyarország Genzyme Europe B.V. Képviselet Tel 36 1 310 7440 Genzyme CEE GmbH . 359 2 971 1001
eská RepublikaSlovenská RepublikaSlovenija Genzyme Czech, s.r.o. Tel 420 227 133 665 Nederland Genzyme Europe B.V. Tel 31 35 699 1200
Österreich Genzyme Austria GmbH Tel 43 1 774 65 38 DanmarkNorgeSverigeSuomiFinland Ísland Genzyme AS, DanmarkTanskaDanmörk TlfPuh.Sími 45 32 71 2600
Deutschland Genzyme GmbH Tel 49 610236740 PolskaEestiLatvijaLietuva Genzyme Polska Sp. z o.o. PoolaPolijaLenkija Tel 48 22 24 60 900
Genzyme Hellas Ltd 30 210 99 49 270 Portugal Genzyme Portugal S.A. Tel 351 21 422 0100
España Genzyme, S.A. Tel 34 91 6591670 România Genzyme CEE GmbH- Reprezentana pentru România Tel 40 21 24 34 228
France Genzyme S.A.S. Tél 33 0 825 825 863 United KingdomIreland Genzyme Therapeutics Ltd. United Kingdom Tel 44 1865 405200
This leaflet was last approved in